Table 1.
Patient characteristics and 89Zr-immuno-PET scan details
| Patient | mAb | Gender | Injected dose (MBq) | 89Zr-immuno-PET (n = number of VOI) | |||
|---|---|---|---|---|---|---|---|
| D0 | D3 | D4 | D6 | ||||
| 1 | Rituximab | F | 69.8 | 1 | 1 | – | 1 |
| 2 | Rituximab | M | 75.3 | 22 | 22 | – | 22 |
| 3 | Rituximab | M | 79.2 | 2 | 2 | – | 2 |
| 4 | Rituximab | M | 75.0 | 0 a | 1 | – | 1 |
| 5 | Rituximab | F | 75.6 | 6 | 0 | – | 6 |
| 6 | Cetuximab | F | 36.7 | 2 | 2 | – | 2 |
| 7 | Cetuximab | M | 35.6 | 2 | 2 | – | 2 |
| 8 | Cetuximab | F | 36.2 | 2 | 2 | – | 2 |
| 9 | Cetuximab | F | 36.5 | 1 | 1 | – | 1 |
| 10 | Cetuximab | F | 35.5 | 2 | 0 | – | 2 |
| 11 | Cetuximab | M | 38.1 | 0 b | 0 | – | 1 |
| 12 | Trastuzumab | F | 35.0 | – | – | 5 | – |
| 13 | Trastuzumab | F | 38.2 | – | – | 4 | – |
| 14 | Trastuzumab | F | 35.8 | – | – | 5 | – |
| 15 | Trastuzumab | F | 37.3 | – | – | 4 | – |
| 16 | Trastuzumab | F | 38.3 | – | – | 5 | – |
| 17 | Trastuzumab | F | 35.3 | – | – | 2 | – |
| 18 | Trastuzumab | F | 37.0 | – | – | 3 | – |
| Total | 40 | 103 | |||||
aTechnical error: 1 VOI missing for patient 4
bNo D0 scan available: 1 VOI missing for patient 11
D0 VOI were delineated on D6 and imported to the D0 scan (data marked in italics)